RECURSION PHARMACEUTICALS IN shareholders Q3 2023

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 190 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.9%.

RECURSION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Lindbrook Capital, LLC 452$3,4580.00%
Janney Montgomery Scott LLC 15,270$1170.00%
TORONTO DOMINION BANK 74$5660.00%
DEUTSCHE BANK AG\ 59,688$456,6130.00%
Amundi 88,562$565,0260.00%
Belvedere Trading LLC 6,340$48,5010.00%
Belvedere Trading LLC 5,500$42,0750.00%
Clearstead Advisors, LLC 250$1,9140.00%
MERCER GLOBAL ADVISORS INC /ADV 14,259$1090.00%
Belvedere Trading LLC 7,600$58,1400.00%
COMERICA BANK 266$2,0350.00%
Invesco Ltd. 107,090$819,2390.00%
Cutler Group LLC / CA 100$00.00%
NATIONAL BANK OF CANADA /FI/ 1,650$11,7170.00%
WOLVERINE TRADING, LLC 14,300$109,3950.00%
WOLVERINE TRADING, LLC 17,200$131,5800.00%
BANK OF MONTREAL /CAN/ 10,810$92,9660.00%
RAYMOND JAMES & ASSOCIATES 69,188$529,2880.00%
Cutler Group LLC / CA 1,600$00.00%
JANE STREET GROUP, LLC 35,564$272,0650.00%
External links

This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q3 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.